![Dov Goldstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dov Goldstein
Directeur Financier/CFO chez
BIOAGE LABS, INC.
Fortune : 372 538 $ au 31/07/2026
Profil
Dov A. Goldstein currently works at ADMA Plasma Biologics, Inc., as Director, Gain Therapeutics, Inc., as Independent Director from 2021, Coya Therapeutics, Inc., as Independent Director from 2021, and BioAge Labs, Inc., as Chief Financial Officer from 2021.
Dr. Goldstein also formerly worked at MIA Dynamics Motors Ltd., as Chairman & Chief Executive Officer from 2006 to 2014, RIGImmune, Inc., as President, CEO, Treasurer & Director from 2018 to 2020, NeuBase Therapeutics, Inc., as Chairman from 2022 to 2025, Esperion Therapeutics, Inc., as Independent Director from 2008 to 2019, Cempra Pharmaceuticals, Inc., as Director from 2009 to 2013, Topaz Pharmaceuticals, Inc., as Director, ADMA Biologics, Inc., as Independent Non-Executive Director from 2007 to 2020, Cempra, Inc., as Director from 2008 to 2011, HealthCare Ventures LLC, as Director-Venture Analysis, Global Pay (P.C.S) Ltd., as Director, Scerene Healthcare, Inc., as Director, Durata Therapeutics, Inc., as Interim Co-President & Independent Director from 2009 to 2012, Neubase Therapeutics, Inc., as Director, Geom Therapeutics, Inc., as Director, Vicuron Pharmaceuticals LLC, as Chief Financial Officer & Executive Vice President from 2001 to 2005, Aisling Capital LLC, as Operating Partner from 2006 to 2019, Schrödinger, Inc., as Chief Financial Officer from 2017 to 2018, RCMC Capital LLP, as Managing Partner from 2014 to 2019, Loxo Oncology, Inc., as Chief Financial Officer from 2014 to 2015, and Indapta Therapeutics, Inc., as Chief Financial & Business Officer from 2020 to 2021.
Dr. Goldstein received his undergraduate degree in 1990 from Stanford University, Masters Business Admin degree from Columbia Business School, and doctorate degree from Yale School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOAGE LABS, INC. 0,08% | 23/04/2026 | 36 575 ( 0,08% ) | 330 638 $ | 31/07/2026 |
| 01/05/2026 | 10 000 ( 0,04% ) | 41 900 $ | 31/07/2026 | |
| 15/07/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Postes actifs de Dov Goldstein
| Sociétés | Poste | Début |
|---|---|---|
| GAIN THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/01/2021 |
| COYA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/03/2021 |
| BIOAGE LABS, INC. | Directeur Financier/CFO | 01/11/2021 |
ADMA Plasma Biologics, Inc.
 ADMA Plasma Biologics, Inc. BiotechnologyHealth Technology Develops medicines for treatment of infectious diseases | Directeur/Membre du Conseil | 04/11/2009 |
Anciens postes connus de Dov Goldstein
| Sociétés | Poste | Fin |
|---|---|---|
| NEUBASE THERAPEUTICS, INC. | Président | 04/01/2025 |
Indapta Therapeutics, Inc.
 Indapta Therapeutics, Inc. BiotechnologyHealth Technology Develops proprietary, off-the-shelf, allogeneic natural killer cell therapy to treat cancer | Directeur Financier/CFO | 01/11/2021 |
| ADMA BIOLOGICS, INC. | Directeur/Membre du Conseil | 18/06/2020 |
RIGImmune, Inc.
 RIGImmune, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biopharmaceutical research company that develops RNA immunotherapies | Directeur Général | 01/01/2020 |
| ESPERION THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/05/2019 |
Formation de Dov Goldstein
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
63
Relations au 1er degré
27
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 27 |
|---|---|
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Aisling Capital LLC
 Aisling Capital LLC Investment ManagersFinance Aisling Capital invests in both private and public companies located in the Unites States. The firm targets companies operating in the fields of developing & commercializing important and innovative healthcare products, services & technologies sectors and industries. It provides financing for royalty deals, large cap leveraged buyout, seed, early and late stage capital requirements in the form of equity and debt. | Finance |
Cempra Pharmaceuticals, Inc.
 Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops medicines for treating drug-resistant bacterial infections | Health Technology |
Topaz Pharmaceuticals, Inc.
 Topaz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which focuses on developing and commercializing treatments for the pediatric and dermatology markets | Health Technology |
ADMA Biologics, Inc.
 ADMA Biologics, Inc. BiotechnologyHealth Technology Develops, manufactures and markets specialty biologics | Health Technology |
MIA Dynamics Motors Ltd.
 MIA Dynamics Motors Ltd. Trucks/Construction/Farm MachineryProducer Manufacturing Develops off-road all-terrain vehicles and wheel platforms | Producer Manufacturing |
Cempra, Inc.
 Cempra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in manufacturing pharmaceutical products | Health Technology |
HealthCare Ventures LLC
 HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures invests in companies located in the United States. The firm target companies operating in the fields of life sciences, pharmaceuticals and biotechnology. It provides financing for early and later stage capital requirements. | Finance |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galileo Tech Ltd.
 Galileo Tech Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the operation of waste recycling plant and in the financial technology sectors | Commercial Services |
Schrödinger, Inc.
 Schrödinger, Inc. Packaged SoftwareTechnology Services Develops physics-based software platform which enables discovery of novel molecules for drug development and materials applications | Technology Services |
ADMA Plasma Biologics, Inc.
ADMA Plasma Biologics, Inc. BiotechnologyHealth Technology Develops medicines for treatment of infectious diseases | Health Technology |
Scerene Healthcare, Inc.
 Scerene Healthcare, Inc. Medical/Nursing ServicesHealth Services Develops and delivers personal care solutions | Health Services |
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics for infectious diseases and acute illnesses | Health Technology |
RCMC Capital LLP
 RCMC Capital LLP Financial ConglomeratesFinance Provides investment services | Finance |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicine for cancer treatment | Health Technology |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioAge Labs, Inc.
 BioAge Labs, Inc. BiotechnologyHealth Technology Develops therapies obesity for metabolic diseases | Health Technology |
Geom Therapeutics, Inc.
 Geom Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of antibiotic for MDR gram negative infections | Commercial Services |
Neubase Therapeutics, Inc. /Old/
 Neubase Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops peptide-nucleic acid antisense oligonucleotide platform | Health Technology |
NeuBase Therapeutics, Inc.
 NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders | Health Technology |
Indapta Therapeutics, Inc.
Indapta Therapeutics, Inc. BiotechnologyHealth Technology Develops proprietary, off-the-shelf, allogeneic natural killer cell therapy to treat cancer | Health Technology |
Gain Therapeutics, Inc.
 Gain Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Coya Therapeutics, Inc.
 Coya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on research and development of therapies to enhance the function of regulatory T cells | Health Technology |
RIGImmune, Inc.
RIGImmune, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biopharmaceutical research company that develops RNA immunotherapies | Commercial Services |
